Abstract
Objective:
To describe early and mid-term outcomes of Viabahn stenting for extensive aorto-iliac occlusive disease involving the external iliac artery.
Methods:
In this single center retrospective study, all consecutive patients in whom a covered self-expanding Viabahn stent was implanted (W.L Gore & Associates, Inc., Flagstaff, AZ–USA) in the external iliac artery for symptomatic TASC II C and D lesions between 2012 and 2020 were included. Lesions limited to the iliac artery were treated percutaneously. Iliac lesions extending down to the common femoral artery were treated with a hybrid approach. Patency, major adverse limb events, target lesion revascularization (TLR) and limb salvage rates were estimated using Kaplan-Meier curves.
Results:
Out of 118 limbs, 48 (41%) were treated for claudication, 33 (28%) for rest pain, and 37 (31%) for tissue loss. Lesions were TASC C (n = 43 limbs, 36%) or TASC D (n = 75 limbs, 64%). Chronic total iliac occlusions were identified in 26 limbs (22%). Concomitant common femoral artery lesions were recorded in 97 limbs (82%). All lesions involved the external iliac artery. Technical success was achieved in 100% of cases. Six (5.7%) perioperative major adverse cardiovascular events occurred, including 4 (3.8%) deaths. Eleven (7.6%) early major adverse limb events were recorded. Two-years primary patency, assisted primary patency and secondary patency were 85%, 88%, and 95%, respectively. After multivariate analysis, small-diameters stents (<8 mm) was associated with lower primary patency rates (HR 3.20, 95% CI 1.26-8.13, P = .014) and lower freedom from TLR rates (HR 2.61, 95% CI 1.02-6.66, P = .045). Adjunctive common femoral artery endarterectomy was significantly associated with higher primary patency rates (HR 0.38 95% CI 0.15-0.95, P = .038).
Conclusion:
The use of Viabahn self-expanding covered stents for extensive aorto-iliac disease involving the external iliac artery provided acceptable post-operative morbidity and high rates of mid-term secondary patency, similar to those usually reported with aortobifemoral bypass. Adjunctive common femoral artery endarterectomy was a major determinant of patency and should be considered an essential component of the treatment strategy. Additional long-term data are necessary to evaluate the role of self-expanding covered stents for the treatment of such lesions.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
